Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Claessens

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
BMC Cancer|June 11, 2024
Feasibility and potential effectiveness of nurse-led video-coaching interventions for childhood, adolescent, and young adult cancer survivors: the REVIVER studyEline Bouwman, Iridi Stollman, Joyce Wilbers, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.
Acta Oncologica (Stockholm, Sweden)|February 10, 2022
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancerAnouk K M Claessens, Jan J V Busschbach, Bram L T Ramaekers, et al.
International Journal of Obesity (2005)|September 16, 2014
Percentile reference values for anthropometric body composition indices in European children from the IDEFICS studyP Nagy, E Kovacs, L A Moreno, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 21, 2020
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE RegistryAnouk K M Claessens, Bram L T Ramaekers, Dorien J A Lobbezoo, et al.
Breast Cancer Research and Treatment|August 20, 2018
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)Anouk K M Claessens, Monique E M M Bos, Marta Lopez-Yurda, et al.
Cancer|March 7, 2023
Desire for children among male survivors of childhood cancer: A DCCSS LATER studyJoyce J M Claessens, Adriaan Penson, Ewald M Bronkhorst, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
Cancer|December 6, 2023
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS-LATER studyJoyce J M Claessens, Adriaan Penson, Ewald M Bronkhorst, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysisJelle E Bousema, Martijn van Dorp, Fieke Hoeijmakers, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
BMC Cancer|June 11, 2024
Feasibility and potential effectiveness of nurse-led video-coaching interventions for childhood, adolescent, and young adult cancer survivors: the REVIVER studyEline Bouwman, Iridi Stollman, Joyce Wilbers, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.
Acta Oncologica (Stockholm, Sweden)|February 10, 2022
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancerAnouk K M Claessens, Jan J V Busschbach, Bram L T Ramaekers, et al.
International Journal of Obesity (2005)|September 16, 2014
Percentile reference values for anthropometric body composition indices in European children from the IDEFICS studyP Nagy, E Kovacs, L A Moreno, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 21, 2020
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE RegistryAnouk K M Claessens, Bram L T Ramaekers, Dorien J A Lobbezoo, et al.
Breast Cancer Research and Treatment|August 20, 2018
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)Anouk K M Claessens, Monique E M M Bos, Marta Lopez-Yurda, et al.
Cancer|March 7, 2023
Desire for children among male survivors of childhood cancer: A DCCSS LATER studyJoyce J M Claessens, Adriaan Penson, Ewald M Bronkhorst, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
Cancer|December 6, 2023
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS-LATER studyJoyce J M Claessens, Adriaan Penson, Ewald M Bronkhorst, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysisJelle E Bousema, Martijn van Dorp, Fieke Hoeijmakers, et al.
Pageof 7